Shockwave Medical Finds $35M For Cardiovascular Therapy

Fremont-based Shockwave Medical, a developer of technology to treat calcified plaque that contributes to cardiovascular disease, has raised $35M in an extension of its Series C funding, the company said today

The story you have requested is only available to paid members of the web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.